57
https://pubmed.ncbi.nlm.nih.gov/38117316
This correction article confirms that circulating hsa-miR-221 could serve as a potential diagnostic and prognostic biomarker for diabetic nephropathy.
“Circulating hsa-miR-221 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy: Confirmation from Correction Article”
